




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
讲课淋巴结为转移在贲门癌中的研究进展Theincidenceofadenocarcinomaoftheesophagogastricjunction
(AEG)isincreasing。
Theincidenceofesophagealadenocarcinomarosefrom0.13for1935-1971to0.74for1974-1989,andtheincidenceofadenocarcinomaoftheesophagogastricjunctionrosefrom0.25to1.34per100,000person-years.whereasthatofdistalgastric
adenocarcinomahassteadilydecreased.2PeraM,CameronAJ,TrastekVF,CarpenterHA,Zinsmeister
AR.Increasingincidenceofadenocarcinomaoftheesophagusandesophagogastricjunction.Gastroenterology1993;104:510–3.BlotWJ,DevesaSS,KnellerRW,etal.:Risingincidenceof
adenocarcinomaoftheesophagusandgastriccardia.JAMA
1991;265:1287–1289.ReferencesCardiagastriccarcinomaORadenocarcinomaoftheesophagogastricjunction(AEG)?
3Definition&classificationhistologyClinicalsiewertAEG
I:between5cmand1cmoralofthejunctionAEGII:between1cmoraland2cmaboralofthejunctionAEGIII
:2cmand5cmaboralofthejunction4siewert1999theinternationalsocietyfordiseaseoftheesophagus(ISDE)THEinternationalgastriccancerassociation(IGCA)Classification5.SiewertJR,SteinHJ:Classificationofadenocarcinomaoftheoesophagogastricjunction.BrJSurg1998;85:1457–1459References
theclinicalsymptomsofthesetumorsareoftenquitevagueandtendtointensifyonlygraduallyinseverityoveralongperiodoftime,mostpatientsarefirstdiagnosedwhenthesecarcinomasalreadyarelocallyadvanced。
Theonlychanceforlongtermsurvivalforthesepatientsisacomplete(InternationalUnionAgainstCancer[UICC]R0)removalofthetumor。TytgatGN.Barrett’sesophagus:isitallthatbad?CanJGastroenterol1999;13:385–8References5theimportanceofNstatusOneofthekeyfactorsthatdeterminestheprognosisofpatientswithtumorsthroughoutthegastrointestinaltractistheinvolvementbytumorofregionallymphnodes(Nstatus)ForpatientswithAEG,theNstatushasbeenshowntobeanindependentprognosticfactor。YamashitaH,KataiH,MoritaS,etal.OptimalextentoflymphnodedissectionforSiewerttypeIIesophagogastricjunctioncarcinoma.Annalsofsurgery2011;254:274-280.recurrenceAlthoughsurgicaltechniqueshaveimproved,theoverallprognosisforpatientswiththesetumorsremainspoorprimarilyduetolocaltumorrecurrenceandthedevelopmentofdistantmetastasesNatsugoeS,MuellerJD,KijimaF,AridomeK,ShimadaM,ShiraoK,etal.Extranodalconnectivetissueinvasionandtheexpressionofdesmosomalglycoprotein1insquamouscellcarcinomaoftheoesophagus.BrJCancer1997;75:892–7.SiewertJR,SteinHJ,SendlerA,FinkU.Surgicalresectionforcancerofthecardia.SeminSurgOncol1999;17:125–31.JaklRJ,MiholicJ,KollerR,MarkisE,WolnerE.Prognosticfactorsinadenocarcinomaofthecardia.AmJSurg1995;169:316–9ReferencesNigroJJ,DeMeesterSR,HagenJA,DeMeesterTR,PetersJH,KiyabuM,etal.Nodestatusintransmuralesophagealadenocarcinomaandoutcomeafterenblocesophagectomy.JThoracCardiovascSurg1999;117:960–87TherecurrenceratesoftypeI,II,andIIItumorswere57.1%,44.4%,and41.0%,respectively.ThemostfrequentrelapsesitewaslymphogenousintypeI,hematogenousintypeII,anddisseminativeintypeIIItumors.Themediantime-to-recurrenceaftersurgerywas12.6monthsintypeI,12.5monthsintypeII,and12.7monthsintypeIIIdisease,withnosignificantdifference.RecurrencepatternsofesophagogastricjunctionadenocarcinomaaccordingtoSiewert'sclassificationafterradicalresection;AnticancerRes.2014Aug;34(8):4391-7LNMMMicrometastasiswasdefinedastumorcellclustersmeasuringfrom0.2mmto2.0mmintheirgreatestdimension,andarecommonlyidentifiedbyimmuno-histochemistry(IHC)butcanbeconfirmedbyroutineHE。isolatedtumorcells(ITC)aredefinedassingletumorcellsorsmallclustersofcellsmeasuring≤0.2mmintheirgreatestdimension。macrometastasis,MAlymphnodemicrometastasisUICC&AJCCGreeneFL.AJCCCancerStagingManual[M].NewYork:SpringerVerlag,2002:111-119References8MuellerJD,SteinHJ,OyangT,etal.Frequencyandclinicalimpactoflymphnodemicrometastasisandtumorcellmicroinvolvementinpatientswithadenocarcinomaoftheesophagogastricjunction.Cancer2000;89:1874-1882.References9howtofindimmunohistochemistry(IHC)Ber-EP4AE1/AE3CK19CD44V6(CAM5.2;E-CAD;CCR7;CXCR4)reverse
transcription-polymerasechainreaction(RT-PCR)10howtofindimmunohistochemistry(IHC)Ber-EP4AE1/AE3CK19、20CD44V6(CAM5.2;E-CAD;CCR7;CXCR4)reverse
transcription-polymerasechainreaction(RT-PCR)11Ber-Ep4foundin1990byULatza,GNiedobitek,RSchwarting,HNekarda,HSteinBer-Ep4isanantibodyagainst
twoglycopolypeptidesof34and39kDonthesurface
andthecytoplasmofallepithelialcellsexceptforthe
superficiallayersofsquamousepithelia,parietalcells,
andhepatocytes.Theantibodydoesnotcross-reactwith
mesenchymaltissueincludinglymphoidtissue.LatzaU,NiedobitekG,SchwartingR,etal.:Ber-EP4:Newmonoclonalantibodywhichdistinguishesepitheliafrommesothelial.JClinPathol1990;43:213–219.stomachMammaryglandReferences12howtofindimmunohistochemistry(IHC)Ber-EP4AE1/AE3CK19CD44V6(CAM5.2;E-CAD;CCR7;CXCR4)reverse
transcription-polymerasechainreaction(RT-PCR)13RT-PCRRT-PCRassayisthoughttobefarmore
sensitivethantheimmunohistochemicalmethod。RT-PCRassayidentifiedlymphnodemicrometastasisin31.3%ofpatients,whereasIHCdetectedlymphnodemicrometastasisin11.3%ofpatients。SeveralstudieshavereportedanRT-PCRanalysistodetectthepositiveexpressionofCEA,CK19,orCK20mRNAin5.3-23.8%oftheLNsthatarefreefromhistologicalmetastasis。.AberrantGeneMethylationintheLymphNodesProvidesaPossibleMarkerforDiagnosingMicrometastasisinGastriccancer
AnnSurgOncol(2010)17:1177–1186Assessmentofmelanoma-initiatingcellmarkersandconventionalparametersinsentinellymphnodesofmalignantmelanoma;ActaMed.Okayama,2015Vol.69,No.1,pp.17-27References14problemsfalse-positives&false-negativessensitivity
&
specificityFirst,false-positivesmaybeproducedbyRT-PCRbecauseofthecontaminationorthepresenceofpseudogene
.Second,thereisapossibilityoffalse-negativesbecauseoftheheterogeneousexpressionoftargetmarkers。itssensitivityandspecificitywerereportedas88.9%and96.6%,respectively。Clinicalsignificanceofmoleculardiagnosisforgastriccancerlymphnodemicrometastasis;WorldJGastroenterol2014October14;20(38):13728-13733CurrentStatusandScopeofLymphNode;JGastricCancer2015;15(1):1-9/10.5230/jgc.20References1516sentinelnode(SN)newtreatmentprognosticClinicalSignificanceofLymphNodeMicrometastasissignificanceintraoperationpostoperation
preoperationlymphadenectomyintraoperativeiagnostictool17sentinelnode(SN)newtreatmentprognosticofClinicalSignificanceofLymphNodeMicrometastasissignificanceintraoperationpostoperation
preoperationlymphadenectomyintraoperativeiagnostictoolIfaminimallyinvasivesurgerycouldbeperformedtotreatesophagealcancer,themortalityrateaftersurgeryandthepostsurgicalqualityof
lifecouldimprove.Regardingsurgicaltreatment,minimally
invasive
mucosalresection
(EMR),endoscopicsubmucosaldissection(ESD),andblunt
dissectionarechosenandperformedbasedonthestageand
preoperativeconditionsofpatients.18Thesentinelnode(SN)conceptwasfirstadvocatedby
Mortonetal.inpatientswithmelanoma.SNbiopsyforbreast
cancerandmalignantmelanomahasbeenaccepted
worldwideasausefultechniqueforassessmentoflymph
nodestatus.sentinelnode(SN)VeronesiU,PaganelliG,GalimbertiV,etal.Sentinel-nodebiopsytoavoidaxillarydissectioninbreastcancerwithclinicallynegativelymph-nodes.Lancet.1997;349:1864–7.EdwardsMJ,MartinKD,McMastersKM.Lymphaticmappingandsentinellymphnodebiopsyinthestagingofmelanoma.SurgOncol.1998;7:51–7.
preoperationReferencesDetectionofSentinelNodesOnedaybeforesurgery,3mCi(2mL)of
99mTechnetium-tincolloid(adioisotope(RI)colloid)was
endoscopicallyinjectedintothesubmucosaoftheesophagealwallatfoursites(0.5mLeach)aroundthetumorusingadisposable23-gaugeneedle(MAJ-75,
Olympus,okyo,Japan).Lymphoscintigraphywasperformed2hafterRIinjection.Duringsurgery,theuptakeof
RIineachlymphnodewascountedusingNavigatorGPS
(TYCOHEALTHCARE,Ltd.,Tokyo,Japan).After
surgery,theabsenceofresidualradioactivitywasintraoperativelyconfirmedbyNavigatorGPSinthecervical,mediastinal,andabdominalfields.AlldissectedlymphnodesweremappedandRIuptakewasmeasuredagain.LymphnodeswithRIcountsfivetimesgreaterthan
backgroundlevelswereclassifiedashotnodesandwere
definedassentinelnodes(SNs).AssessmentofSentinelNodeConceptinEsophagealCancerBasedonLymphNodeMicrometastasisAnnSurgOncol(2013)20:3031–3037
preoperationReferences20sentinelnode(SN)newtreatmentprognosticofClinicalSignificanceofLymphNodeMicrometastasissignificanceintraoperationpostoperation
preoperationlymphadenectomyintraoperativeiagnostictoolLymphaticSpreadandMicroinvolvementin
AdenocarcinomaoftheEsophago-GastricJunctionJournalofSurgicalOncology2006;94:307–315intraoperationLymphnodesweresampledandgroupedintothree
compartments:(1)mediastinallymphnodes,(2)lymph
nodesadjacenttothetumor,(3)upperabdominal
nodes.intraoperationFrequencyandClinicalImpactofLymphNode
MicrometastasisandTumorCellMicroinvolvementin
PatientswithAdenocarcinomaoftheEsophagogastric
Junction
1.MuellerJD,SteinHJ,OyangT,etal.Frequencyandclinicalimpactoflymphnodemicrometastasisandtumorcellmicroinvolvementinpatientswithadenocarcinomaoftheesophagogastricjunction.Cancer2000;89:1874-1882.intraoperationReferencesintraoperativediagnostictoolTodevelopRT-PCRassayasanintraoperativediagnostictoolforthedetectionofLNM,RT-PCRassayneedstoenablerapidanalysisduringoperationaswellastoretainhighsensitivityandspecificity.Yaguchietal.recentlyreportedtheutilityofone-stepnucleicacid
amplification(OSNA).OSNAcantakeapproximately30min
todiagnosethepresenceorabsenceoflymphnode
metastasis.OSNAexaminesonlyCK19
expression,thesensitivityandspecificityinastudyof162
lymphnodesamplesobtainedfrom32patientswithgastric
cancerwere88.9%and96.6%,respectively.thismolecularsystemcouldbea
promisingtoolforintraoperativedetectionofLNMwhen
performingminimallyinvasivesurgerywithpersonalized
lymphadenectomyinpatients.YaguchiY,SugasawaH,TsujimotoH,etal.One-stepnucleicacidamplification(OSNA)fortheapplicationofsentinelnodeconceptingastriccancer.AnnSurgOncol.2011;18:2289–96.intraoperationReferences25sentinelnode(SN)newtreatmentprognosticofClinicalSignificanceofLymphNodeMicrometastasissignificanceintraoperationpostoperation
preoperationlymphadenectomyintraoperativeiagnostictool1.RuY,ZhangL,ChenQ,etal.Detectionandclinicalsignificanceoflymphnodemicrometastasisingastriccardiaadenocarcinoma.TheJournalofinternationalmedicalresearch2012;40:293-299.postoperation2004and2010Noneofthepatientshadreceived
preoperativechemotherapyorradiotherapy.ThepresenceofCK19-positiveor
CD44v6-positivecellswassignificantlyrelatedtodepthofinvasion(P=0.043andP=0.046,respectively)andLauren
classification(P=0.019andP=0.007,respectively),butnottoage,sex,tumoursize
ordegreeofdifferentiation.1.SchurrPG,YekebasEF,KaifiJT,etal.Lymphaticspreadandmicroinvolvementinadenocarcinomaoftheesophago-gastricjunction.Journalofsurgicaloncology2006;94:307-315.SurvivalSchurr
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年教育技术发展:《囊萤夜读》课件新里程
- 土地转让合同书怎样写(3篇)
- 2024年青海省西宁市中考一模考试地理试题(解析版)
- 建设工程安全协议书
- 产品拍摄指南:打造专业产品摄影效果
- 市场调研手册市场研究分析与预测方法
- 高速公路边坡绿化防护
- 办公室设备故障排除
- 2025年四季之美课件:感悟季节的变迁
- 2025年十堰如何考货运从业资格证
- 反假币测试附有答案
- 怎样调动员工积极性
- 2024年内科护理学(第七版)期末考试复习题库(含答案)
- 【上市公司的财务风险的分析和防范:以三只松鼠为例10000字(论文)】
- 急诊科培训急诊科与其他科室的协作与沟通
- JCT414-2017 硅藻土的标准
- 肌肉注射评分标准
- 钢结构主要技术标准和要求
- 腊八粥 第一课时自学导学单
- 掺合料讲义课件
- 中美关系新时代52张课件
评论
0/150
提交评论